Culture
September 13, 2021

Support for India: COVID-19 Relief

Culture
April 27, 2021

Support for India: COVID-19 Relief

Author

LARVOL is proud to be a global company, connecting teammates from 14 countries around the world. Many of our tigers live and work in India, where COVID-19 cases are once again soaring.

To help those interested in advocating for support from the U.S. Government, we’ve gathered these instructions and suggested language for outreach to US Representatives and Senators. Feel free to share with those in your network to encourage continued support!

How to Find your Representative in the House:

-        Visit House.gov website

-        Enter your zip code to search for your Representative

-        Click the email icon beneath the Representative’s photo

-        This will take you to their webpage and you can email them directly

How to Find your Senators in the Senate:

-        Visit Senate.gov website

-        Choose your state from the drop down

-        Click Contact beneath the Senator’s photo

-        This will take you to their webpage and you can email them directly

Suggested Language:

I stand with Myron Billiant, Executive Vice President and Head of International Affairs at the U.S. Chamber of Commerce, in calling on the administration to distribute U.S. vaccine supplies to international partners, specifically to India, as they are facing a dire crisis.

As Myron stated on April 24, 2021, “As the Covid pandemic inflicts a heavy toll on countries around the globe, the U.S. Chamber strongly encourages the administration to release the millions of AstraZeneca vaccine doses in storage - as well as other life-saving support - for shipment to India, Brazil, and other nations hard-hit by the pandemic. These vaccine doses will not be needed in the United States, where it’s estimated that vaccine manufacturers will be able produce enough doses by early June to vaccinate every American. This move would affirm U.S. leadership, including in initiatives such as COVAX, and as we work with partners around the globe because no one is safe from the pandemic until we are all safe from it.”

We welcome everyone to join us in supporting India with a small donation to our charity with Direct Relief. Read more and make a donation here.

Download attached file
Not rated
Allison Betof Warner, MD, PhD (she/her) 4
3743
Manhattan, NY
November 10, 2022

79% had reduction in disease. ORR 31%. Many responses deepen over time.

Not rated
Allison Betof Warner, MD, PhD (she/her) 3
3743
Manhattan, NY
November 10, 2022

Median DOR not yet reached. Median OS 13.9 mo. 12 mo OS was 54%. As typical with immunotherapy, we see a nice tail on the curve. #TIL#SITC22

Positive
Alex Shoushtari, MD
2253
New York, USA
November 10, 2022

Important work on efficacy of TIL therapy lifileucel in PD-1 resistant #melanoma being presented at #SITC22. Pretty good durability for this heavy lift of a treatment.

Not rated
Allison Betof Warner, MD, PhD (she/her) 2
3743
Manhattan, NY
November 10, 2022

Toxicity profile was in line with prior TIL/Lifileucel data. No surprises here. Median # doses of IL-2 was 6.

Positive
Hussein Tawbi, MD, PhD
1685
Houston, TX
November 10, 2022

Absolutely agree!… this should be available to our melanoma patients ASAP!… and paves the way for smarter cellular therapies to be designed, studied, and eventually widely disseminated

Positive
Allison Betof Warner, MD, PhD (she/her) 1
3744
Manhattan, NY
November 10, 2022

Where does this leave us with #TIL therapy for #melanoma? IMO, this response rate/durability justifies accelerated approval. Pts with PD-1 refractory melanoma need options. It’s FAR from a perfect tx but provides meaningful clinical benefit. What say you melanoma Twitterverse?

Not Rated
Sumanta K. Pal, MD, FASCO
15083 Followers
Los Angeles, CA
November 8, 2022

Just before I start AM clinic at @cityofhopeoc, excited to share results from #COBALT_RCC, a P1 trial of @CRISPRTX#CTX130 in #kidneycancer in the @sitcancer#PressProgram. Will present more on Thurs 5:37p at #SITC22! Thx @neerajaiims@DrBenTran@HaanenJohn#SamerSrour& co-Is! t.co/aDnhG9n92A

not rated
Shilpa Gupta
5095 Followers
Cleveland, OH
November 8, 2022
Not Rated
Tian Zhang, MD, MHS
6463 Followers
Dallas, TX
November 8, 2022

CAR-Ts are coming for #kidneycancer!! Congratulations @montypal and team; can’t wait to see results at #SITC22! t.co/9MrlF2yzBe

Not Rated
Moshe Ornstein MD
1930 Followers
Cleveland, OH
November 8, 2022

Congrats @montypal and team! Great to see CAR T therapy coming to #RCCt.co/ypRHBC89Pt

Not Rated
Shuchi Gulati MD
12476 Followers
Seattle, WA
November 8, 2022

Another huge step from none other than @montypal!! CAR-Ts in #kidneycancer!Congratulations to the entire team!Looking forward to seeing the results at #SITC22! t.co/HvKeVBPyV7

Not Rated
Petros Grivas
12476 Followers
Seattle, WA
November 8, 2022

Subscribe to our newsletter

Sign up for our newsletter to get the latest news, updates and high-impact data delivered directly to your inbox.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.